...
首页> 外文期刊>Bioorganic and medicinal chemistry >New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives
【24h】

New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives

机译:新的褪黑素(MT1 / MT2)配体:(8,9-dihydro-7H-furo [3,2-f] chromen-1-yl)衍生物的设计与合成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Herein we describe the synthesis of novel tricyclic analogues issued from the rigidification of the methoxy group of the benzofuranic analogue of melatonin as MT1 and MT2 ligands Most of the synthesized compounds displayed high binding affinities at MT1 and MT2 receptors subtypes Compound 6b (MT1, Ki = 0.07 nM; MT2, Ki = 0.08 nM) exhibited with the vinyl 6c and allyl 6d the most interesting derivatives of this series Functional activity of these compounds showed full agonist activity with EC50 in the nanomolar range Compounds 6a (EC50 = 0.8 nM and Emax = 98%) and 6b (EC50 = 0.2 nM and Emax = 121%) exhibited good pharmacological profiles
机译:本文中,我们描述了由褪黑激素的苯并呋喃类似物的MT1和MT2配体的苯并呋喃类似物的甲氧基的刚性化而发出的新型三环类似物的合成。大多数合成化合物在MT1和MT2受体亚型化合物6b(MT1,Ki = 0.07 nM; MT2,Ki = 0.08 nM)与乙烯基6c和烯丙基6d一起显示是该系列中最有趣的衍生物,这些化合物的功能活性在纳摩尔范围的化合物EC5上显示出完全的激动剂活性和EC50(EC50 = 0.8 nM和Emax = 98%)和6b(EC50 = 0.2 nM和Emax = 121%)表现出良好的药理作用

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号